HILL-ROM HOLDINGS for HILL-ROM HOLDINGS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Diabetic retinopathy
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JEFFERS | — |
Veterans VET
VA Procurement and payment reforms; prompt pay, veterans choice program issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JEFFERS | — |
Taxation/Internal Revenue Code TAX
COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748; Sec. S965 and GILTI; the HEROES Act (H.R. 6800)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JEFFERS | — |
Health Issues HCR
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748);and the Heroes Act (H.R.6800) Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JEFFERS | — |
Medicare/Medicaid MMM
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074),the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS JEFFERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.